SCHEMBL6300804

SCHEMBL6300804

COc1ccc(NC(=O)c2cccc(-c3ccccc3OC)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
RAB9A P51151 7/20 0.62
NPC1 O15118 6/20 0.62
CASP3 P42574 1/20 0.59
SENP7 Q9BQF6 1/20 0.59
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
MAPT P10636 2/20 0.58
TSHR P16473 2/20 0.58
HSD17B10 Q99714 1/20 0.58
GAA P10253 1/20 0.57
KAT6A Q92794 1/20 0.57
PLG P00747 1/20 0.57
PLAU P00749 1/20 0.57
PLAT P00750 1/20 0.57
KCNK9 Q9NPC2 1/20 0.56
ADORA3 P0DMS8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6294661 0.90 MEN1 (0.61) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL6295715 0.89 KMT2A (0.58) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL6294910 0.86 RAB9A (0.60) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL6295706 0.86 TAS1R3 (0.61) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL15413191 0.82 NPC1 (0.78) RAB9ANPC1CASP3SENP7MEN1
SCHEMBL13741991 0.80 FFAR1 (0.57) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL13742588 0.80 PNLIP (0.49) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL4186005 0.80 SMN1; SMN2 (0.71) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL4174639 0.80 NPC1 (0.74) POLBCYP1A2CYP3A4RAB9ANPC1
SCHEMBL6802217 0.80 NPC1 (0.83) RAB9ANPC1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK POLB 1876/4885CYP1A2 2211/4885CYP3A4 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.